Carine Coneglian de Farias

Highly specific changes in antioxidant levels and lipid peroxidation in Parkinson’s disease and its progression: Disease and staging biomarkers and new drug targets

Carine Coneglian de Farias, Michaël Maes, Kamila Landucci Bonifácio et al. · Neuroscience Letters · 2016 · 128 citations · Full text

Life Sciences, Neurobiology, Neuroscience +17

Clozapine and olanzapine are better antioxidants than haloperidol, quetiapine, risperidone and ziprasidone in in vitro models

Francis F. Brinholi, Carine Coneglian de Farias, Kamila Landucci Bonifácio et al. · Biomedicine & Pharmacotherapy · 2016 · 70 citations

Medicine, Pharmacology, Pharmacotherapy +11

Lowered paraoxonase 1 (PON1) activity is associated with increased cytokine levels in drug naïve first episode psychosis

Francis F. Brinholi, Cristiano Noto, Michaël Maes et al. · Schizophrenia Research · 2015 · 37 citations

Medicine, Pharmacology, Psychiatry +5

Parkinson's Disease is Accompanied by Intertwined Alterations in Iron Metabolism and Activated Immune-inflammatory and Oxidative Stress Pathways

Carine Coneglian de Farias, Michaël Maes, Kamila Landucci Bonifácio et al. · CNS & Neurological Disorders - Drug Targets · 2017 · 34 citations · Full text

Life Sciences, Neurobiology, Neuroscience +17

Natural regulatory IgM‐mediated autoimmune responses directed against malondialdehyde regulate oxidative and nitrosative pathways and coupled with IgM responses to nitroso adducts attenuate depressive and physiosomatic symptoms at the end of term pregnancy

Chutima Roomruangwong, Décio Sabbatini Barbosa, Carine Coneglian de Farias et al. · Psychiatry and Clinical Neurosciences · 2017 · 21 citations · Full text

Life Sciences, Immunology, Obstetrics +17